Skip to content
Save up to 80% on your medications — Fast delivery
Prandin
Guaranteed quality
Discreet shipping
Returns

Prandin

5 customer reviews
Delivery: 4–7 days
Secure payment methods
24/7 Support
Active ingredient: Repaglinide
Package Per unit Price
SSL Secure
Certified pharmacy
Money-back guarantee

Prandin is an oral diabetes medicine containing repaglinide, a meglitinide that stimulates insulin release. It is for adults with type 2 diabetes who need better control of after-meal blood sugar rises. It helps lower post-meal glucose by prompting the pancreas to release insulin around mealtimes.

What is it?

Repaglinide: The Active Ingredient

Repaglinide is the active ingredient in Prandin. It works only if the pancreas still has functioning beta cells, which is why it is used in type 2 diabetes and not in type 1 diabetes.

Mechanism of Action: Stimulating Insulin Release

Repaglinide stimulates the pancreas to release insulin by closing ATP-dependent potassium channels on pancreatic beta cells, which leads to calcium entry and insulin secretion. The practical meaning is simple: when you take it before a meal, it boosts the insulin response your body should be making as glucose rises. This is why timing is a big deal with Prandin.

Practical tip: If your meal timing is unpredictable, Prandin is often easier to fit in than longer-acting options because you tie each dose to a main meal rather than to a fixed morning schedule.

Composition

The active ingredient in Prandin is repaglinide, a short-acting meglitinide that prompts meal-time insulin release. It is supplied as oral tablets in several strengths (commonly 0.5 mg, 1 mg, and 2 mg) so the dose can be matched to meal size.

Alongside the active substance, the tablets contain inactive excipients that give the tablet its form and stability — typically fillers and binders such as microcrystalline cellulose, calcium hydrogen phosphate, maize starch, povidone, glycerol, and magnesium stearate, with colourants in some strengths. Exact excipients vary by manufacturer and strength, so check the leaflet if you have known excipient sensitivities.

How to use?

Take Prandin by mouth shortly before each main meal.

  • Timing: take it about 15 minutes before eating; it can be taken immediately before a meal, up to 30 minutes before.
  • If you skip a meal: skip that dose.
  • If you add an extra main meal: take an extra dose for that meal, as directed in your plan.
  • If you take a dose and then cannot eat: treat that situation like hypoglycemia risk, since the insulin release may still be triggered.
Practical tip: Many people set a “plate in front of me” rule—Prandin is taken when food is certain, not when you are only thinking about eating.

How does it work?

  • Route: Oral (tablet)
  • Typical starting dose: 0.5 mg before each main meal (up to 3 times/day)
  • Dose range per meal: 0.5–4 mg taken 15–30 minutes before eating; if a meal is skipped, skip that dose
  • Maximum dose: 4 mg per meal; 16 mg/day total
  • Duration: Taken daily as long-term therapy as prescribed; dose is adjusted based on blood glucose results

Indications

Prandin is used to manage type 2 diabetes by lowering elevated blood sugar (hyperglycemia), with a focus on after-meal control. Better postprandial control can help bring down overall glycemic exposure, which is often reflected in HbA1c trends over time. The WHO highlights that preventing long-term diabetes complications relies on sustained glucose control alongside lifestyle measures and risk-factor management such as blood pressure and lipids [3].

Prandin is not used to treat type 1 diabetes. It is not used for diabetic ketoacidosis.

Comparison

Prandin contains repaglinide. Alternatives are other oral diabetes medications that lower blood glucose through different mechanisms, and sometimes they are combined in one regimen.

Key oral alternatives by class and mechanism:

  • Biguanide: Metformin helps reduce glucose production in the liver and improves insulin sensitivity.
  • Sulfonylureas: Glipizide, Glimepiride, Glyburide lower blood glucose by increasing insulin release, but they tend to last longer than repaglinide.
  • DPP-4 inhibitors: Sitagliptin, Linagliptin, Alogliptin, Saxagliptin increase incretin activity and support glucose-dependent insulin release.
  • SGLT2 inhibitors: Dapagliflozin, Empagliflozin increase urinary glucose excretion and can reduce weight and blood pressure in some patients.
  • Thiazolidinediones: Pioglitazone and Rosiglitazone improve insulin sensitivity in muscle and fat.
  • Alpha-glucosidase inhibitors: Acarbose and Miglitol slow carbohydrate absorption in the gut to blunt post-meal glucose rises.
  • Other meglitinide: Nateglinide is in the same broader “meal-time insulin secretagogue” category.

Prandin Compared with Common Oral Options

Option Drug class Main best-fit use-case
Repaglinide (Prandin) Meglitinide Post-meal glucose spikes; flexible mealtimes
Metformin Biguanide First-line base therapy in many adults; insulin resistance
Sitagliptin DPP-4 inhibitor Modest HbA1c lowering with low hypoglycemia risk when used alone

Trade-offs matter. Prandin can be very effective for meal-related spikes, but it can cause hypoglycemia, and it adds a “dose-with-meals” routine that some people find tiring. Metformin does not target meals as directly, yet it does not usually cause hypoglycemia on its own. DPP-4 inhibitors are often easier day-to-day, but their glucose-lowering effect may be less pronounced for sharp postprandial peaks.

Contraindications

  • Type 1 diabetes mellitus
  • Diabetic ketoacidosis
  • Severe liver dysfunction
  • Concomitant use of gemfibrozil
  • Hypersensitivity to repaglinide or tablet components

Not recommended for

Prandin may not be suitable if any of the following apply:

  • You have type 1 diabetes.
  • You have diabetic ketoacidosis.
  • You have serious liver problems.
  • You take gemfibrozil at the same time.
  • You have ever had an allergic reaction to repaglinide or any tablet ingredients.

Side effects

The side effect that matters most with Prandin is hypoglycemia (low blood sugar), since repaglinide increases insulin release. Other reported effects include nausea, diarrhea, headache, back pain, joint pain, and cold-like symptoms such as nasal congestion or sore throat. Rarely, symptoms suggestive of liver injury can occur (for example jaundice or dark urine), and urgent medical assessment is needed in that scenario.

Signs of hypoglycemia can include sweating, tremor, hunger, fast heartbeat, headache, sudden irritability, or confusion. Some people only notice “I can’t think straight” or “I got snappy for no reason.”

Practical tip: If you use a beta-blocker for blood pressure or rhythm, the usual warning sign of hypoglycemia (a racing heart) can be muted; look for sweating, unusual fatigue, or sudden trouble concentrating.

Common mistakes

Taking Prandin correctly is more about timing than willpower.

  • Taking a dose and then skipping the meal. This is the fastest route to hypoglycemia.
  • Using it for snacks. Prandin is usually planned for main meals; frequent “grazing” makes dosing messy and increases lows.
  • Doubling up after a high reading. A single high post-meal number is often a meal-size issue; stacking doses can cause delayed hypoglycemia.
  • Treating hypoglycemia with “diet” drinks. You need fast carbohydrates (glucose tablets, regular juice), not zero-sugar options.
  • Changing exercise intensity without watching readings. A long walk after dinner can drop glucose more than expected when Prandin is onboard.

One sentence that comes up a lot: “I took it, then the meeting ran late.” Planning around real life is part of using Prandin well.

Doctor opinions

In clinical practice, prescribers often reach for repaglinide when a patient’s main problem is post-meal glucose spikes, or when meal times vary from day to day. It can also be used alongside other oral diabetes medicines, but the prescriber will usually reduce overlapping “insulin-releasing” drugs to keep hypoglycemia risk under control. Clinicians also watch for a pattern: people who eat small meals may do better than people who “graze” all day, because Prandin is built around defined meals, not continuous snacking.

One more real-world point doctors raise: hypoglycemia from repaglinide can be easy to miss if symptoms feel like “stress” (shaky hands, sweating, irritability), so structured self-monitoring matters when starting or changing the dose.

A single dose that is too high for your meal size can cause low blood sugar. A dose that is too low can leave you high after meals.

Frequently asked questions

Prandin is designed for meal-time control, so its glucose-lowering effect begins around the time glucose is rising after eating. Many people see an effect on post-meal readings from the first days when timing is consistent. EMA product information for repaglinide describes it as short-acting, which is why it is taken shortly before meals rather than once daily. In clinical practice, the biggest determinant of early success is matching the dose to meal size.

Skip the Prandin dose for that meal. The purpose of Prandin is to stimulate insulin release around food intake, so taking it without eating raises hypoglycemia risk. MOHAP diabetes education materials stress aligning medicines with meals as part of safe self-management. If skipped meals are frequent, clinicians often rethink the regimen.

Yes, repaglinide is sometimes combined with metformin because they target glucose in different ways. Metformin reduces hepatic glucose output, while Prandin increases meal-time insulin secretion from the pancreas. WHO diabetes guidance supports combination therapy when single-drug control is insufficient, paired with lifestyle measures. Dose planning matters to avoid hypoglycemia when multiple agents are used.

Weight changes vary by person, but medicines that increase insulin secretion can be associated with modest weight gain in some patients, often driven by reduced glucose loss and extra calories used to treat lows. Keeping hypoglycemia rare helps avoid “defensive snacking,” a common reason weight creeps up. EMA safety information links hypoglycemia to insulin secretagogues, and frequent lows can indirectly affect appetite and weight patterns. Tracking meals and post-meal readings for two weeks gives clearer answers than the scale alone.

Common signs include sweating, tremor, hunger, dizziness, headache, irritability, and confusion. If you take a beta-blocker, palpitations may be less noticeable, so watch for sweating and sudden fatigue. MOHAP patient guidance for diabetes self-care in the UAE includes recognizing and treating hypoglycemia promptly as a core safety skill. Recurrent lows mean the dose, meal size, or activity plan needs adjustment.

Generic repaglinide contains the same active ingredient and is expected to provide the same clinical effect when used the same way. Regulators require bioequivalence testing so blood levels fall within an accepted range compared with the reference product. EMA standards for generics are designed to make switching feasible without loss of efficacy. After any switch, checking post-meal readings for several days is a practical way to confirm the regimen still fits your meals.

Front view Front view
Side view Side view
Back view Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.

Prandin — Comparison with alternatives

Prandin, Diet, and Exercise

Prandin works best when meals are consistent in carbohydrate amount and timing. Diet and exercise are not optional add-ons; they set the baseline that Prandin builds on. Regular activity improves insulin sensitivity, so your body needs less insulin to handle the same glucose load, and your Prandin plan may need adjustment as your fitness improves.

A practical way to use Prandin well is to match it to predictable, repeatable meals. If your dinner is sometimes light and sometimes heavy, after-meal readings can swing widely even with the same dose.

Practical tip: When you change your routine—Ramadan fasting patterns, night shifts, travel across time zones—re-check your after-meal glucose for a few days so dosing stays aligned with real meal timing.

Reviews and Experiences

K
Khalid, 54
Dubai
10 weeks
Verified
My biggest issue was high numbers after dinner. I took Prandin 15 minutes before meals and the after-meal spikes came down within the first week. I had two mild lows when dinner was lighter than usual.
14/02/2026
M
Mariam, 47
Abu Dhabi
6 weeks
Verified
It worked for post-meal glucose, but I had nausea for the first few days and a headache in week one. Once I stopped taking it before ‘maybe’ meals and only took it when food was certain, I felt steadier.
27/01/2026
O
Omar, 60
Sharjah
3 months
Verified
Good control after lunch and dinner. The downside was I had to carry glucose tablets because one time I got shaky in the supermarket. My doctor adjusted the plan after I started walking more in the evenings.
05/03/2026
H
Huda, 39
Al Ain
4 weeks
Verified
I liked the flexibility with shifting meal times, but I found the routine annoying during busy work days. On days I snacked instead of eating a real lunch, I ended up with a low and learned that Prandin isn’t a ‘snack medicine’ for me.
18/12/2025
N
Nadia, 50
Ajman
2 weeks
Verified
I’m giving it 3 stars because it did lower my after-lunch readings, but I had to be very strict about timing. If I delayed food by even a little, I felt shaky and had to use glucose tablets.
09/04/2026

Sources

  1. MOHAP (Ministry of Health and Prevention) (2026). Diabetes: Patient Education and Self-Management Guidance (UAE).
  2. European Medicines Agency (EMA) (2026). Repaglinide: Summary of Product Characteristics (SmPC).
  3. World Health Organization (WHO) (2026). Diabetes: Fact Sheet and Management Recommendations.
  4. European Medicines Agency (EMA) (2026). Pharmacovigilance Guidance: Preventing Hypoglycaemia with Insulin Secretagogues.
  5. European Medicines Agency (EMA) (2026). Guideline on the Investigation of Bioequivalence.
Get our free app Shop faster and track your orders 3.8 · 1,437 reviews Install